Terms: = Breast cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148 AND Clinical Outcome
2 results:
1. PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.
Lattanzio R; Iezzi M; Sala G; Tinari N; Falasca M; Alberti S; Buglioni S; Mottolese M; Perracchio L; Natali PG; Piantelli M
BMC Cancer; 2019 Jul; 19(1):747. PubMed ID: 31362705
[TBL] [Abstract] [Full Text] [Related]
2. Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.
Lattanzio R; Marchisio M; La Sorda R; Tinari N; Falasca M; Alberti S; Miscia S; Ercolani C; Di Benedetto A; Perracchio L; Melucci E; Iacobelli S; Mottolese M; Natali PG; Piantelli M;
Int J Cancer; 2013 Mar; 132(5):1022-31. PubMed ID: 22847294
[TBL] [Abstract] [Full Text] [Related]
